Clinical outcomes and molecular characteristics of patients with metastatic pancreatic ductal adenocarcinoma according to involved metastatic sites. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback